» Articles » PMID: 14722307

Removal of N-linked Glycosylation Sites in the V1 Region of Simian Immunodeficiency Virus Gp120 Results in Redirection of B-cell Responses to V3

Overview
Journal J Virol
Date 2004 Jan 15
PMID 14722307
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

One mechanism of immune evasion utilized by human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) envelope glycoproteins is the presence of a dense carbohydrate shield. Accumulating evidence from in vitro and in vivo experiments suggests that alterations in N-linked glycosylation of SIV gp120 can enhance host humoral immune responses that may be involved in immune control. The present study was designed to determine the ability of glycosylation mutant viruses to redirect antibody responses to shielded envelope epitopes. The influence of glycosylation on the maturation and specificity of antibody responses elicited by glycosylation mutant viruses containing mutations of specific N-linked sites in and near the V1 and V2 regions of SIVmac239 gp120 was determined. Results from these studies demonstrated a remarkably similar maturation of antibody responses to native, fully glycosylated envelope proteins. However, analyses of antibodies to defined envelope domains revealed that mutation of glycosylation sites in V1 resulted in increased antibody recognition to epitopes in V1. In addition, we demonstrated for the first time that mutation of glycosylation sites in V1 resulted in a redirection of antibody responses to the V3 loop. Taken together, these results demonstrate that N-linked glycosylation is a determinant of SIV envelope B-cell immunogenicity in addition to in vitro antigenicity. In addition, our results demonstrate that the absence of N-linked carbohydrates at specific sites can influence the exposure of epitopes quite distant in the linear sequence.

Citing Articles

Exploring expression and immune potency in mice using mRNA encoding the malaria antigen, CelTOS.

Waghela I, Mallory K, Taylor J, Schneider C, Savransky T, Janse C Front Immunol. 2023; 13:1026052.

PMID: 36591298 PMC: 9798330. DOI: 10.3389/fimmu.2022.1026052.


Plant-Expressed Receptor Binding Domain of the SARS-CoV-2 Spike Protein Elicits Humoral Immunity in Mice.

Maharjan P, Cheon J, Jung J, Kim H, Lee J, Song M Vaccines (Basel). 2021; 9(9).

PMID: 34579215 PMC: 8472882. DOI: 10.3390/vaccines9090978.


MHC Class I Stability is Modulated by Cell Surface Sialylation in Human Dendritic Cells.

Silva Z, Ferro T, Almeida D, Soares H, Ferreira J, Deschepper F Pharmaceutics. 2020; 12(3).

PMID: 32164343 PMC: 7150992. DOI: 10.3390/pharmaceutics12030249.


V2-Specific Antibodies in HIV-1 Vaccine Research and Natural Infection: Controllers or Surrogate Markers.

Duerr R, Gorny M Vaccines (Basel). 2019; 7(3).

PMID: 31390725 PMC: 6789775. DOI: 10.3390/vaccines7030082.


Monitoring Viral Genetic Variation as a Tool To Improve Molecular Diagnostics for Mumps Virus.

Dilcher M, Barratt K, Douglas J, Strathdee A, Anderson T, Werno A J Clin Microbiol. 2018; 56(10).

PMID: 30021826 PMC: 6156297. DOI: 10.1128/JCM.00405-18.


References
1.
Gram G, HEMMING A, Bolmstedt A, Jansson B, Olofsson S, Akerblom L . Identification of an N-linked glycan in the V1-loop of HIV-1 gp120 influencing neutralization by anti-V3 antibodies and soluble CD4. Arch Virol. 1994; 139(3-4):253-61. DOI: 10.1007/BF01310789. View

2.
Li Y, Luo L, Rasool N, Kang C . Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding. J Virol. 1993; 67(1):584-8. PMC: 237399. DOI: 10.1128/JVI.67.1.584-588.1993. View

3.
Kraiselburd E, Torres J . Properties of virus-like particles produced by SIV-chronically infected human cell clones. Cell Mol Biol (Noisy-le-grand). 1995; 41 Suppl 1:S41-52. View

4.
Schonning K, Jansson B, Olofsson S, Hansen J . Rapid selection for an N-linked oligosaccharide by monoclonal antibodies directed against the V3 loop of human immunodeficiency virus type 1. J Gen Virol. 1996; 77 ( Pt 4):753-8. DOI: 10.1099/0022-1317-77-4-753. View

5.
Edinger A, Ahuja M, Sung T, Baxter K, Haggarty B, Doms R . Characterization and epitope mapping of neutralizing monoclonal antibodies produced by immunization with oligomeric simian immunodeficiency virus envelope protein. J Virol. 2000; 74(17):7922-35. PMC: 112323. DOI: 10.1128/jvi.74.17.7922-7935.2000. View